Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
NCT06294808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1043
Last updated 2025-11-18
Summary
Clinical outcomes after surgical resection in HCC is a continuum and is clearly related to tumor burden but needs better definition. The researchers describe the use of the "metro ticket" approach to analyze surgical outcomes over the whole spectrum of anatomically resectable HCC to define overall survival including intermediate stage tumors (BCLC B). The analysis the researchers provide in this study enables the clinician to select the optimal surgical resection candidate based on robust long term survival data.
In addition, study compares outcome for open surgery vs laparoscopic surgery, survival outcome for viral and non-viral HCC using Albumin-Bilirubin (ALBI) for more comprehensive study result.
On top of that, non-HBV, non-HCV (NBNC) hepatocellular carcinoma (HCC) is generally associated with poorer tumor characteristics. However, it remains unclear whether this leads to worse post-resection survival compared to viral-related HCC. This study evaluates the prognostic impact of viral status and liver function on post-resection survival outcomes between NBNC and viral HCC patients.
This retrospective study also aims to determine if HCC of viral and non-viral etiologies have different clinical outcomes after surgical resection when tumor burden and liver function are considered.
Conditions
- Hepatocellular Carcinoma Resectable
Sponsors & Collaborators
-
Singapore General Hospital
collaborator OTHER -
National Cancer Centre, Singapore
lead OTHER
Principal Investigators
-
Pierce Chow, MD, PhD · National Cancer Centre, Singapore
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-17
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- Singapore
Study Locations
More Related Trials
-
A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice
NCT01460745 ·Status: COMPLETED
-
Surgical Resection for Hepatocellular Carcinoma
NCT06013657 ·Status: COMPLETED
-
Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer
NCT02644603 ·Status: UNKNOWN ·Phase: NA
-
A Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular Carcinoma
NCT05117047 ·Status: COMPLETED
-
Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
NCT01914289 ·Status: UNKNOWN ·Phase: NA
-
Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?
NCT00733200 ·Status: COMPLETED ·Phase: NA
-
Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma
NCT02613156 ·Status: COMPLETED
-
The Outcomes of Laparoscopic Hybrid Surgery Versus Totally Open Surgery
NCT06550700 ·Status: COMPLETED
-
Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study
NCT07311798 ·Status: NOT_YET_RECRUITING
-
Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers
NCT00594529 ·Status: UNKNOWN ·Phase: PHASE2
-
Volume-Restricted Resection for Perihilar Cholangiocarcinoma
NCT07149558 ·Status: NOT_YET_RECRUITING
-
Anatomical Resection in Colorectal Liver Metastases Patients
NCT05673564 ·Status: COMPLETED
-
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS
NCT06317896 ·Status: NOT_YET_RECRUITING
-
Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
NCT00172159 ·Status: UNKNOWN ·Phase: PHASE2
-
Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery
NCT02941861 ·Status: COMPLETED
-
Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer
NCT05540925 ·Status: COMPLETED
-
Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-limited Metastasis
NCT00677586 ·Status: COMPLETED ·Phase: NA
-
Circulating Tumor Cells in mCRC for Liver Resection
NCT03295591 ·Status: UNKNOWN
-
Clinical Characteristics and Prognosis of Simultaneous Versus Delayed Resection for Synchronous Colorectal Liver Metastasis: A Nationwide Multicenter Study Utilizing Propensity Score Matching Analysis
NCT07082335 ·Status: COMPLETED
-
Laparoscopic Surgery VS RFA for Recurrent HCC
NCT02785380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NCT06146946 ·Status: RECRUITING ·Phase: NA
-
Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma
NCT02616926 ·Status: UNKNOWN ·Phase: NA
-
Perioperative Outcomes of Simultaneous Colorectal and Liver Resections
NCT05475041 ·Status: COMPLETED
-
Postoperative Exercise Training and Colorectal Cancer Liver Metastasis
NCT05579340 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis
NCT02886104 ·Status: RECRUITING ·Phase: NA